Regeneron Pharmaceuticals Inc. has signed a nine-year lease expansion with BioMed Realty Trust Inc. for 116,200 s/f at the Landmark at Eastview, bringing the campus to more than 99 percent leased.
The life sciences company now leases more than 1.1 million square feet at The Landmark at Eastview campus in Tarrytown, New York.
BioMed Realty was represented by Transwestern partner Matthew McDevitt in the transaction.
“We are proud to extend our valued relationship with Regeneron Pharmaceuticals,” said BioMed’s Alan D. Gold, chairman and chief executive officer.
“Transwestern is a highly regarded firm that we’ve had the pleasure of working with on a number of significant biotech transactions along the East Coast, and we are excited to continue working with them to build leasing momentum at The Landmark.”
Owned and managed by BioMed Realty, The Landmark at Eastview is one of the largest multi-tenant science parks in the state.
The research park is located 30 minutes from Manhattan in central Westchester County in the Saw Mill River Valley near the Hudson River.
Encompassing 140 acres, it has eight buildings with more than 1.4 million rentable square feet of research and development facilities and high-tech office space.
Peter Capuciati and Alex Blue of Savills Studley represented Regeneron Pharmaceuticals in the transaction.
